Skip to Content
Merck
All Photos(5)

Key Documents

SAB4504740

Sigma-Aldrich

Anti-phospho-FHIT (pTyr114) antibody produced in rabbit

affinity isolated antibody

Sign Into View Organizational & Contract Pricing

Select a Size

100 μG
PLN 1,750.00

PLN 1,750.00

Please contact Customer Service for Availability
All Photos(5)

Select a Size

Change View
100 μG
PLN 1,750.00

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

PLN 1,750.00

Please contact Customer Service for Availability

biological source

rabbit

Quality Level

100

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen 16 kDa

species reactivity

mouse, human, rat

concentration

~1 mg/mL

technique(s)

ELISA: 1:40000
immunohistochemistry: 1:50-1:100

NCBI accession no.

P49789

UniProt accession no.

P49789

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

phosphorylation (pTyr114)

Gene Information

human ... FHIT(2272)

Immunogen

The antiserum was produced against synthesized peptide derived from human FHIT around the phosphorylation site of Tyr114.

Immunogen Range: 80-129

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
118459

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

María A Rodríguez-Hernández et al.
Journal of cellular physiology, 234(1), 692-708 (2018-08-23)
Sorafenib is the unique accepted molecular targeted drug for the treatment of patients in advanced stage of hepatocellular carcinoma. The current study evaluated cell signaling regulation of endoplasmic reticulum (ER) stress, c-Jun-N-terminal kinase (JNK), Akt, and 5'AMP-activated protein kinase (AMPK)

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service